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A 54-year-old male patient was seen in clinic for ocular pain and decreased vision in the right eye with duration of 
two days. He underwent a cataract operation for his right eye 12 years ago, then a sclera-fixated secondary intra-
ocular implantation and pars plana vitrectomy three years ago due to intraocular lens dislocation. At the initial visit, 
his visual acuity was restricted to the perception of hand motion. An edematous cornea, cells, flare with hypopyon, 
and exposed suture material at were observed at the six o’clock direction by slit lamp. Vitreous opacity was noted 
from B-scan ultrasonography. The patient was diagnosed with late-onset endophthalmitis and an intravitreal cock-
tail injection was done. On the next day, the hypopyon was aggravated, and therefore a pars plana vitrectomy was 
performed. A vitreous culture tested positive for Citrobacter koseri. After 12 weeks, the best corrected visual acuity 
of the right eye improved to 0.7 and a fundus examination revealed a relatively normal optic disc and retinal 
vasculature. We herein report the first case of endophthalmitis caused by Citrobacter koseri in Korea. Exposed su-
ture material was suspected as the source of infection in this case and prompt surgical intervention resulted in a rel-
atively good visual outcome. 
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Infectious endophthalmitis is a serious condition in which 
the internal structures of the eye are invaded by micro-
organisms such as bacteria, resulting in an inflammatory re-
sponse that ultimately may involve entire ocular tissues. The 
majority of cases of endophthalmitis occur after surgery, and 
most cases follow cataract extraction, with almost all being 
bacterial in origin. Thus, postoperative endophthalmitis is an 
extremely worrisome and potentially devastating complica-
tion of cataract surgery. 
A significant percentage of cases of infectious endoph-
thalmitis proved to be culture-negative [1,2]. In pseudo-
phakic endophthalmitis, culture-negative cases account for 
25% to 35% of all cases [2-4]. Among culture-positive cases, 
Gram-positive organisms account for 75% to 90%. Gram-negative 
organisms, such as Pseudomonas and Haemophillus, accounted 
for about 6% of culture-positive cases in the Endophthalmitis 
Vitrectomy Study [2,3].
 Despite its rarity, endophthalmitis 
caused by Gram-negative bacteria is known to have a worse 
prognosis than that caused by Gram-positive bacteria. Among 
cases of culture-positive endophthalmitis, Citrobacter species 
are a relatively rare species, and postoperative endophthalmitis 
caused by Citrobacter koseri has not been reported in Korea 
[5-8].
 
We herein report a case of late-onset infectious endoph-
thalmitis caused by Citrobacter koseri (previously called 
Citrobacter diversus), which occurred three years after a sec-
ondary intraocular lens implantation (IOL).  
Case Report
A 54-year-old male patient was seen in clinic for ocular 
pain and decreased vision in the right eye for with duration of 
two days. The patient denied any history of diabetes mellitus, 
hypertension, pulmonary tuberculosis, or any other systemic 
diseases. He underwent a cataract operation in his right eye 
12 years ago. He underwent a secondary IOL implantation 
with sclera fixation and pars plana vitrectomy of the right eye 
three years ago, due to IOL dislocation. 
Initial visual acuity of the right eye was limited to the per-Korean J Ophthalmol Vol.25, No.4, 2011
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Fig. 1. Slit lamp photography of the right eye at initial presentation. 
Severe conjunctival injection and exposed suture material at 6 
o’clock direction were observed. Also, an edematous cornea with 
3.0-mm-height hypopyon was observed. 
Fig. 2. B-scan ultrasonography of the right eye at initial presentation.
Significant vitreous opacity was observed. 
ception of hand movement, while that of the left eye was 0.8 
according to the Snellen visual acuity chart. Initial intra-
ocular pressure was 17 mmHg and 12 mmHg in right and left 
eyes, respectively, according to readings from a non-contact 
tonometer. The patient had mild flu-like symptoms 3 to 4 
days before the onset of ocular pain, although his body tem-
perature at clinic presentation was 36.4℃. Following a slit 
lamp examination of the right eye, it was found that the con-
junctiva was severely injected and exposed prolene suture 
material was noted at the 6 o’clock direction. The cornea was 
edematous with Descemet’s membrane folds and the pupil 
was mid-dilated and fixed. The anterior chamber was hazy 
with cells and flares, and an approximately 3.0 mm-height 
hypopyon was observed (Fig. 1). The lens, vitreous, and fun-
dus were not visualized. Opacity was noted in the vitreous 
cavity according to B-scan ultrasonography (Fig. 2). An orbi-
tal computed tomography with contrast was done for further 
examination and showed no remarkable abnormal finding. 
Routine lab tests, including blood culture, were done and re-
vealed no remarkable result.
We diagnosed the patient as having delayed postoperative 
infectious endophthalmitis due to suture exposure. On the 
same day, samplings of the anterior chamber fluid and vitre-
ous were done under local anesthesia. After sampling, 1.0 
mg/0.1 mL vancomycin (1 g/vial, Vancocin CP; Eli Lilly, Seoul, 
Korea), 2.0 mg/0.1 mL ceftazidime (1 g/vial, Ceftazidime; 
Youngjin Pharmaceutical, Seoul, Korea), and 400 μg/0.1 
mL dexamethasone (5 mg/mL, Dexamethasone; Daewon 
Pharmaceutical, Seoul, Korea) were injected into the vitre-
ous cavity. Anterior chamber fluid and vitreous were sent to 
the lab for cytology, smear, and culture for bacteria and 
fungi. 
Fortified cefazolin (1 g/vial, Cefamezin; Donga Pharmaceutical, 
Seoul, Korea) and fortified tobramycin eye drops (50 mg/2 
mL/vial, Tobra Inj., Daewoong Pharmaceutical; 5 mL/bottle, 
Tobra eye drops, Daewoong Pharmaceutical) were ad-
ministered every hour alternatively, along with a topical ste-
roid eye drop (5 mL/bottle, Predforte eye drops 1%; Allergan, 
Irvine, CA, USA), administered every 2 hours, to be used 
used along with systemic antibiotic and steroid treatments. 
On postoperative day 1 after injection, ocular pain decreased 
but the hypopyon of the anterior chamber increased slightly 
to 4 mm of height and corneal edema was the worsened 
slightly as well. We decided to undergo a pars plana vi-
trectomy and removal of the IOL with exposed suture materi-
al, which was thought to be the source of the infection. 
Pars plana vitrectomy (PPV) with removal of the IOL and 
suture material was done under general anesthesia. During 
the operation, a pus-filled vitreous cavity and some retinal 
hemorrhages were observed. However, significant corneal 
edema and vitreous haziness obscured a detailed examina-
tion of fundus. At the end of the operation, an intravitreal 
cocktail injection was done following the same regimen as 
that of the previous injection.   
On postoperative day 1 after the vitrectomy, visual acuity 
was limited to the perception of hand motion and intraocular 
pressure was within normal range. Following lamp examina-
tion, it was observed that the cornea was still edematous, but 
hypopyon was not observed. The posterior segment was not 
observed due to severe corneal edema, but there was a sig-
nificant decrease in vitreous opacity based on the findings of 
B-sound ultrasonography. All ophthalmic solutions and sys-
temic medications were continued. On postoperative day 2, a 
culture of the vitreous tap revealed growth of Citrobacter 
koseri. This Citrobacter koseri was only resistant to ampicillin, 
and susceptible to second- and third-generation cephalospor-
ins by antibiotic sensitivity test, and therefore we continued 
with the medication. After one week, the visual acuity of the HM Kang, et al. Citrobacter koseri Endophthalmitis with Suture Exposure
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Fig. 3. Twelve weeks after vitrectomy, best corrected visual acuity was improved to 0.7 (refractive errors +12.0 sph –1.50 cyl Ax90), accord-
ing to a Snellen chart examination. (A) Cornea and anterior chamber were both clear. (B) According to a fundus examination, a relatively nor-
mal optic disc and retinal vasculature were observed.  
right eye had improved to counting of fingers at 30 cm. 
Corneal edema was decreased, and the optic disc was visible 
on fundus examination. After 12 weeks, the best corrected 
visual acuity was improved to 0.7 (refractive errors +12.0 sph 
–1.50 cyl Ax90), according to Snellen chart examination. The 
cornea was clear and a fundus examination revealed a rela-
tively normal optic disc and retinal vasculature (Fig. 3).
Discussion
The incidence of postoperative endophthalmitis is now de-
creasing in tendency, and reported to have a frequency of 
0.05 to 0.68% after cataract extraction surgery [9].
 According 
to Doft et al. [10], the incidence of postoperative endoph-
thalmitis was 0.072% (17 / 23,625) after cataract extraction 
with or without IOL implantation, 0.30% (3 / 988) after sec-
ondary IOL implantation, and 0.051% (1 / 1,974) after PPV. 
The incidence of endophthalmitis is also known to be in-
creased after secondary IOL implantation and most likely 
caused by other associated risk factors, including diabetes, 
transscleral suture fixation of the posterior chamber IOL, 
polypropylene haptics, preoperative eyelid abnormalities, re-
entrance through a previous wound, and postoperative 
wound defects [11].
 
 The microbiologic spectrum is one of the most influential 
factors in determining visual outcome in endophthalmitis. 
Less virulent organisms, such as Staphylococci, are asso-
ciated with better initial visual acuity and final visual out-
come [2,12,13].
 The association of the virulence of micro-
organisms with poor visual outcome is proven in several 
studies [14-17].
  
Citrobacter koseri, which was found in our patient, is an 
anaerobic, motile, Gram-negative bacilli and belongs to the 
genus Citrobacter, within the family of Enterobacteriaceae. 
Citrobacter koseri is one of the most common species of the 
Citrobacter genus, and is commonly found in water, soil, and 
as occasional colonizers of the gastrointestinal tract of hu-
mans [17,18].
 Like other virulent Gram-negative organisms, 
endophthalmitis caused by Citrobacter species can be asso-
ciated with a poor visual outcome in spite of maximal 
treatment. Chen et al.
 [8] reported 6 cases of endophthalmitis 
caused by Citrobacter species, of which 4 cases were caused 
by Citrobacter freundii and 2 cases were caused by Citrobacter 
koseri. Final visual acuity was limited to no light perception 
in 5 eyes among 6 cases, although maximal medical and surgi-
cal treatment were undertaken after diagnosis of endophthalmitis.
 
However, in one case caused by Citrobacter koseri, the pa-
tient was able to achieve 20 / 30 vision, according to their re-
port [8].
  
In the current case, we also observed a relatively good vis-
ual outcome with a best corrected visual acuity of 0.7 at 12 
weeks. The initial visual acuity in the patient was limited to 
the perception of hand movement. The Endophthalmitis 
Vitrectomy Study has demonstrated that the vitrectomy was 
beneficial for eyes presenting with vision of light perception 
[2]. Thus, the intravitreal cocktail injection was done imme-
diately after the ophthalmic examination and then the sys-
temic evaluation for general anesthesia was performed for 
further vitrectomy and removal of the IOL in case they be-
came necessary. Postoperative follow-up revealed a definite 
worsening of the hypopyon and inflammation without im-
provement, while the suture remained exposed. The corneal 
edema had worsened as well and we decided to perform a 
PPV with removal of the secondary IOL, in case further de-
compensation of the cornea might obscure the proper view 
for the vitrectomy and IOL removal, which was thought to be 
the ultimate way to improve the endophthalmitis in the 
patient. Prompt surgical intervention, including PPV, re-
moval of the IOL with suture material, and intravitreal anti-
biotic injections resulted in a good prognosis for this case, in-Korean J Ophthalmol Vol.25, No.4, 2011
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dicating that early surgical intervention might result in a bet-
ter visual outcome in cases of Citrobacter koseri infection. 
Also, the patient previously had a PPV at the time of secon-
dary IOL implantation. The vitrectomized eye might have 
limited the virulent growth of the organism, as less endoph-
thalmitis has been reported after the vitrectomy, when com-
pared to cataract surgery or secondary IOL implantation [10].
  
Antimicrobial therapy for Citrobacter infections can be 
problematic, because these species encode chromosomal, in-
ducible ampC β-lactamase genes, which can be expressed 
constitutively at high levels due to mutational changes, con-
ferring resistance to multiple antibiotics [19,20].
  Thus, 
Citrobacter species are resistant to β-lactams such as ampi-
cillin and carbenicillin, and are typically also resistant to er-
ythromycin and other macrolides, clindamycin, and vancomycin. 
Acquired resistance to quinolones and aminoglycosides has 
also been reported. Antibiotic therapy with extended-spectrum 
cephalosporins is known to work against Citrobacter species 
[21].
 In the current case, the organism was resistant to ampi-
cillin but sensitive to the rest of the antibiotics and responded 
well to the vitrectomy and intravitreal cocktail injection.
As far as we are aware, this is the first report of post-
operative endophthalmitis caused by Citrobacter koseri in 
Korea. In the current case, the source of the infection was 
thought to be the exposed suture material and Citrobacter ko-
seri may have penetrated into the eye along the exposed su-
ture material. Thus, it is emphasized again that any exposed 
suture material after secondary intraocular implantation or 
other surgical procedures must be regarded as a possible 
source of endophthalmitis. The exposed suture material, 
thus, must be treated with cauterization or covered with the 
conjunctival flap to prevent any possible infection. Once the 
endophthalmitis occurs, early surgical intervention with 
PPV, removal of the IOL, and intravitreal antibiotics in-
jection might result in a good visual outcome.
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